会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • METHODS AND COMPOSITIONS FOR THE DETECTION OF OVARIAN DISEASE
    • 用于检测卵巢疾病的方法和组合物
    • WO2006010047A2
    • 2006-01-26
    • PCT/US2005024359
    • 2005-07-08
    • TRIPATH IMAGING INCBEYER WAYNE F JRVENETTA THOMAS MICHAELGROELKE JOHN WBLAESIUS RAINER H
    • BEYER WAYNE F JRVENETTA THOMAS MICHAELGROELKE JOHN WBLAESIUS RAINER H
    • G01N33/574
    • G01N33/57449C12Q1/6886C12Q2600/112C12Q2600/158G01N33/57488G01N2333/4725
    • Methods and compositions for identifying ovarian cancer in a patient sample are provided. The methods of the invention comprise detecting overexpression of at least one biomarker in a body sample, wherein the biomarker is selectively overexpressed in ovarian cancer. In preferred embodiments, the body sample is a serum sample. The biomarkers of the invention include any genes or proteins that are selectively overexpressed in ovarian cancer, including, for example, acute phase reactants, lipoproteins, proteins involved in the regulation of the complement system, regulators of apoptosis, proteins that bind hemoglobin, heme, or iron, cytostructural proteins, enzymes that detoxify metabolic byproducts, growth factors, and hormone transporters. In some aspects of the invention, overexpression of a biomarker of interest is detected at the protein level using biomarker-specific antibodies or at the nucleic acid level using nucleic acid hybridization techniques. Kits for practicing the methods of the invention are further provided.
    • 提供了用于鉴定患者样品中卵巢癌的方法和组合物。 本发明的方法包括检测身体样品中至少一种生物标志物的过表达,其中生物标志物在卵巢癌中选择性地过量表达。 在优选的实施方案中,身体样品是血清样品。 本发明的生物标志物包括在卵巢癌中选择性过表达的任何基因或蛋白质,包括例如急性期反应物,脂蛋白,参与补体系统调节的蛋白质,细胞凋亡调节剂,结合血红蛋白的蛋白质,血红素, 或铁,细胞结构蛋白,解毒代谢副产物,生长因子和激素转运蛋白的酶。 在本发明的一些方面,使用生物标志物特异性抗体或在核酸水平使用核酸杂交技术在蛋白质水平上检测目标生物标志物的过表达。 还提供了用于实施本发明的方法的试剂盒。